We have characterized viral -cell interactions of hepatitis C virus (HCV) and liver cells to study the pathogenesis of HCV infection. HepG2 cells constitutively expressing HCV core protein showed apoptotic changes in response to stimulation with anti-Fas monoclonal antibody. Cells treated with the antibody showed extensive cell rounding, shrinkage, and cytoplasmic blebbing and finally detached from plates. Fragmentation of the chromatin was observed in the nucleus and DNA ladders were detected. In contrast, cells expressing HCV envelope, nonstructural proteins or normal HepG2 cells did not exhibit such Fas-mediated apoptosis. However, expression of Fas receptor was not upregulated on the surface of the cells expressing HCV core protein. Apoptotic cell death was prevented by pretreatment with a specific inhibitor of the cysteine protease CPP32, while the specific inhibitor of interleukin-1b-converting enzyme did not show the preventive effect. The results suggest (i) that intracellular expression of HCV core protein makes cells prone to apoptotic death without upregulation of surface Fas expression and (ii) that the CPP32 protease plays a part in the apoptosis effector pathway of HCV coreexpressing cells.
INTRODUCTION operation with ras oncogene (Ray et al., 1996) . Hepatitis C virus (HCV) is a positive strand RNA virus, Apoptotic cell death plays an important role in the belonging to the Flaviviridae family. It is a major causcytopathogenicity induced by several viruses (Hinshaw ative agent of parenterally transmitted non-A non -B hepaet al., 1994; Kawanishi, 1993; Laurent-Crawford et al., titis (Choo et al., 1989) . A main characteristic feature 1993; Ubol et al., 1996) . For example, Jeurissen et al. of HCV infection is its persistent nature and the high (1992) have shown that the virus-induced apoptosis is frequency of chronicity. Chronic hepatitis may evolve into responsible for depletion of thymocytes in young chickliver cirrhosis and also into hepatocellular carcinoma ens infected with chicken anemia virus. In acute human .
immunodeficiency virus (HIV) infection, low-molecularAlthough immunologically mediated and virus-induced weight DNA accumulates in the nucleoplasm of infected mechanisms have been proposed, the pathogenesis of cells, indicating that cytopathic effects of HIV are associ-HCV-associated liver damage is not well understood yet. ated with apoptosis . The lack of an efficient replication system for HCV in cell
In the case of hepatitis, however, involvement of culture has hampered the determination of whether HCV apoptosis in its pathogenicity is not clear. So far only proteins have any direct roles in the immune-mediated histochemical examinations of biopsy samples from paliver cell damage and in the viral persistence.
tients with viral hepatitis have been reported to show Nucleotide sequences of the gene coding for HCV core apoptosis of hepatocytes (Kerr et al., 1979) . Fas-mediated protein are well conserved among strains obtained from apoptosis of hepatocytes has been recently suggested various parts of the world (Bukh et al., 1994) . Antibodies by detecting Fas antigen in the liver tissue with infiltrating to core protein are most frequently detected in patients mononuclear cells in patients with hepatitis C (Hiramatsu and carriers infected with HCV (Chiba et al., 1991) . Furet al., 1994) . It is thus important to examine whether thermore, data have been accumulating to suggest that apoptotic pathways account for the liver cell damage in in addition to functioning in the formation of nucleocapacute and chronic hepatitis. sids the HCV core protein has a regulatory function for
We have established various liver cell lines constituother gene expression (Kim et al., 1994; Shih et al., 1993;  tively expressing HCV proteins to study viral-cell interac- Ray et al., 1995) . It is also recently reported that HCV tions in HCV-infected cells (Harada et al., 1995a,b tein (Barba et al., in press) . Hepatitis is considered to be dene difluoride membrane (Immobilon, Millipore Ltd., Japan). After blocking in nonfat milk solution (Block Ace, the sum total of phenomena of viral-cell interactions in liver cells, and the above data are suggestive of HCV Yukijirushi Co., Sapporo, Japan), the membrane was probed with HCV anti-core monoclonal antibody (Suzuki core protein's role in the apoptotic pathway.
To investigate the effects of intracellular HCV core et al., 1995) as primary antibody and incubated for 1 hr at 37Њ. After being washed, the membrane was further protein in relation to Fas-mediated apoptosis, we studied the susceptibility of the HepG2 cell line constitutively incubated with horseradish peroxidase-conjugated sheep anti-mouse immunoglobulins as secondary antiexpressing HCV core protein to anti-Fas antibody.
body. Antigen -antibody complexes were visualized by enhanced chemiluminescence detection system (ECL,
MATERIALS AND METHODS
Amersham International, Buckinghamshire, England) acCells and plasmids cording to the manufacturer's protocol. To establish HepG2, a human hepatoblastoma cell Indirect immunofluorescence analysis line, constitutively expressing HCV core protein, cells were transfected with the plasmid pcEF39neo. The plasAfter being washed with phosphate-buffered saline mid carries the cDNA coding for HCV core protein (amino (PBS), cells were fixed with methanol-acetone (1:1 v/v) acid position 1-194) (Takeuchi et al., 1990) under the for 10 min at 020Њ. Fixed cells were incubated with control of the EF1-a promoter (Uetsuki et al., 1989) . Cells mouse monoclonal antibodies raised against HCV core were also transfected with the expression vector pcEF32-E1 and E2 proteins diluted to 1:100 in PBS for 60 min at 1swxneo as a negative control (Kim et al., 1994; Harada 20Њ . The secondary antibody was fluorescein isothiocyaet al., 1995b) . HepG2 cells constitutively expressing HCV nate (FITC)-conjugated goat anti-mouse IgG (TAGO, Bur-E1-E2 proteins or nonstructural proteins were obtained lingame, CA) diluted to 1:100 in PBS. Cells were incuby transfecting cells with the plasmids pcEF827 and bated for a further 30 min before observation. pcEF3269 carrying the HCV coding regions corresponding to amino acid positions 155-810 (E1-E2) and 974-Fluorescent ELISA immunoassay 2212 (from the C-terminal of NS2 to the N-terminal half of HCV core protein expressed in each cell clone was NS5A), respectively (Harada et al., unpublished, 1995b) . quantitated by fluorescent ELISA immunoassay (FEIA) HepG2 cells were maintained in Dulbecco's modified (Tanaka et al., 1995) . For FEIA 10 5 cells were lysed in Eagle's medium (DMEM)-F12 supplemented with 10% fe-TNE buffer [10 mM Tris -HCl (pH 7.8), 150 mM NaCl, 1 tal bovine serum, 2 mM glutamine, 100 IU/ml of penicillin, mM EDTA, 1% NP-40] and then processed according and 100 mg/ml of streptomycin and plated on collagento the manufacturer's instruction (International Reagents coated dishes. Cells were transfected by calcium phosCo., Kobe, Japan). The relative fluorescence intensity was phate precipitation method (Pharmacia Biotech, Tokyo, determined by ELSIA-F3000 reader. Japan), as previously described (Harada et al., 1995b) . After transfection transformants were selected in DMEMAnti-Fas antibody and proteases inhibitors treatment F12 medium containing 1 mg/ml of G418 (Gibco BRL, Gaithersburg, MD). The isolated G418-resistant colonies To test the cytocidal effect of anti-Fas, each estabwere designated Hep39 (expressing core protein), lished cell line was treated for 24 hr with 0.25 mg/ml of Hepswx (transfected with expression vector), Hep827
anti-human Fas mAb in culture medium containing 2% (expressing E1 and E2 proteins), and Hep3269 (express-FCS. Three clones of Hep39 cells and one respective ing nonstructural proteins; Harada et al., 1995b) .
clone of Hep827 and Hep3269 cells were tested. Hepswx and untransfected HepG2 cells were also tested as negReagents ative controls.
To examine the effect of the apoptosis inhibitors, A murine anti-human Fas monoclonal antibody, CH-11
Hep39 cell lines were pretreated for 2 hr with 100 mM clone (anti-Fas mAb) (Yonehara et al., 1989) , was pureither Ac-YVAD-cho or Ac-DEVD-cho. Cells were further chased from MBL, Nagoya, Japan. The tetrapeptides Acincubated at 37Њ with anti-Fas mAb (0.25 mg/ml) for 24 YVAD-cho (specific inhibitor of interleukin-1b-converting hr in the presence of each inhibitor. enzyme) and Ac-DEVD-cho (specific inhibitor of CPP32/ apopain) were purchased from Peptide Institute, Inc., Nuclear staining Osaka, Japan.
For detection of changes in nuclear chromatin, cells

Immunoblotting analysis
were fixed in methanol -acetic acid (3:1 v/v) for 10 min at 020Њ. The cell nuclei were stained with 4,6-diamidino-2-Expression of core protein was detected by Western blotting. Cell lysates from 10 6 cells were separated by phenylindole (DAPI) (0.1 mg/ml in PBS) for 5 min in the dark. After washing in PBS, nuclear samples were 12.5% SDS -PAGE and electrotransferred to polyvinyli-mounted in Mowiol (Calbiochem-Novabiochem Co., La RESULTS Jolla, CA) and visualized under a fluorescence microExpression of HCV proteins in stable transfectants scope with a uv filter.
Expression of HCV core protein in stable transfectants was examined by immunoblot analysis. Figure 1A shows DNA fragmentation assay the expression of 22-kDa HCV core protein detected in three different clones of established Hep39 cells. The For DNA fragmentation analysis, adherent and floating molecular weight of the detected protein is in agreement cells were harvested and washed in PBS. Total DNA was with that reported for HCV capsid protein in mammalian extracted by incubating cells in 10 mM and insect cells (Harada et al., 1991; Suzuki et al., 1995) . containing 10 mM EDTA and 0.5% Triton X-100, for 5 min HCV core protein was localized in the cytoplasm of all on ice. After centrifugation at 12,000 rpm for 15 min at Hep39 clones examined, as determined by immunofluo-4Њ, the supernatants were incubated with RNase A (5 rescence (Fig. 1B, a) . We further quantitated HCV core mg/ml, Sigma, Miyata Kagaku, Tokyo, Japan) overnight at protein expressed in each cell line by FEIA (Tanaka et 37Њ, followed by 2 hr incubation at 50Њ with proteinase K al., 1995) . Expression levels of HCV core protein in cell (200 mg/ml, Sigma) and 0.5% SDS. After extraction with clones were almost the same (Fig. 1A) . Expression levels phenol/chloroform, fragmented DNA was precipitated of other HCV proteins in other stable transformants were with ethanol and 5 M NaCl and analyzed by 1.5% agarose also examined by immunofluorescence analysis. Algel in TBE buffer. DNA fragmentation was analyzed for though the staining was not as bright as that of core three clones of both Hep39 and Hepswx cell lines and protein in Hep39 cells, both E1 and E2 proteins were for HepG2 cells under identical conditions, after 24 hr detected in almost all Hep827 cells (Fig. 1B, b and c). incubation with anti-Fas antibody.
Immunofluorescence analysis of nonstructural proteins in Hep3269 was reported previously (Harada et al., Analysis of apoptosis by flow cytometry 1995b).
For flow cytometry analysis of cells undergoing apoSensitivity to Fas-mediated apoptosis of Hep39 ptotic death after treatment with anti-Fas antibody, adherent and floating cells were pooled and washed with cold
To examine the susceptibility of HepG2 cells expresscitrate buffer (250 mM sucrose, 40 mM trisodium citrate, ing HCV core protein to Fas-mediated apoptosis, cells 20% DMSO). Cell pellets were incubated for 10 min at were treated with anti-Fas mAb, as described under Maroom temperature (RT) with 0.03% trypsin solution conterials and Methods. Apoptotic cell death was evaluated taining 3.4 mM trisodium citrate, 1.5 mM spermine, 0.5 on the basis of morphological and nuclear changes of mM Tris, and 0.01% NP-40 (pH 7.6). The samples were cells, nuclear DNA fragmentation, and flow cytometry further incubated for 10 min after addition of trypsin inhibanalysis. We found that interaction of Fas with anti-Fas itor (0.5 mg/ml, Sigma) and RNase A (0.1 mg/ml, Sigma).
antibody induced marked apoptosis in HCV core-exCells were then stained with propidium iodide (0.4 mg/ pressing HepG2 cell lines, while it failed to induce apoml) for 10 min at RT. The samples were analyzed by a ptotic cell death in control Hepswx and HepG2 cells. displayed severe shrinkage together with cytoplasmic blebbing. Most of the apoptotic cells were detached from the plate and were floating in the medium (Fig. 2) . We Analysis of Fas expression on cell surface also stimulated HepG2 transformant cell lines with various monoclonal antibodies to examine their interactions. The expression of Fas antigen on HepG2, Hepswx, and Hep39 cells was analyzed by flow cytometry using
We used antibodies to MHC class I, IL-6 receptor and CD54 which were all well-expressed on the surface of the mouse anti-human Fas mAb (CH-11) as primary antibody. Adherent cells were detached and washed with those cell lines. No apparent apoptosis was observed in cells treated with those antibodies after 24 hr of incuba-DMEM-F12 medium containing 2% FCS. Aliquots of 10 6 cells were incubated with 20 mg/ml of CH-11 mAb for 30 tion (data not shown). Nuclear staining with DAPI showed condensed chromin on ice. After washing, cells were incubated with FITC-conjugated goat anti-mouse immunoglobulins (Biomatin at the periphery of the nuclear membrane and fragmentation of chromatin into small round bodies, charsource International, Inc., Tago Products, USA) as second antibody for further 30 min on ice. After final washing acteristic of apoptotic nuclei (Fig. 3) . In contrast, cells transfected with the expression vector alone or untranscells were analyzed by a FACScan flow cytometer (Becton-Dickinson).
fected HepG2 cells did not show any signs characteristic of apoptotic morphology after anti-Fas treatment (Fig. 2B level. Hep39 cell culture exhibited high levels of apoptotic and Fig. 3B ). Detection of apoptotic changes in all three cells (44-55%), whereas the control Hepswx cell lines clones of Hep39 cells examined indicated that sites of showed only background levels of apoptosis (11%) under integration in stable transformants of Hep39 cells did not identical conditions. Cells expressing core protein in the influence their response to anti-Fas mAb.
absence of stimulation with anti-Fas antibody did not Although some exceptional cases have been deshow any apoptosis. HepG2 cells constitutively expressscribed where apoptotic death occurs in the absence of ing HCV envelope proteins, Hep827, and nonstructural DNA fragmentation (Oberhammer et al., 1993) , internu-HCV proteins, Hep3269, indicated low levels of apoptosis cleosomal degradation of DNA, characterized by the ap-(5 and 13%, respectively), not significantly different from pearance of DNA ladders due to activation of nuclear controls. This is consistent also with the lack of morphoendonucleases, is considered a hallmark of cells underlogical and nuclear apoptotic changes in HepG2 cells going apoptosis (Willie et al., 1982) . In Hep39 cells, degradation of DNA produced typical oligonucleosomal DNA ladders after anti-Fas treatment in all clones (Fig. 4) . In contrast, control and untransfected HepG2 cells did not show any degradation of the DNA under identical conditions.
Apoptosis rates on flow cytometry analysis
Rates of apoptosis after anti-Fas treatment were determined by the appearance of hypodiploid DNA peaks on propidium iodide (PI) staining and flow cytometry analysis (Fig. 5) show any clear apoptotic population above background 
Analysis of apoptotic effector pathway in Hep39 cells
It has recently been demonstrated that interleukin-1b-converting enzyme (ICE) (Kuida et al., 1995) and several other identified ICE-like cysteine proteases are involved in the effector pathway of apoptosis (Fernandes-Alnemri et al., 1994; Tewari et al., 1995; Nicholson et al., 1995) . To investigate the possible involvement of ICE or an ICE- cells was much higher than the background level (20%) (Fig. 6) . It was close to the levels of apoptosis in Hep39 cells treated with anti-Fas in the absence of any protease harboring HCV envelope or nonstructural proteins. These cells and the controls (Hepswx and HepG2) did not show apoptotic cell death even when cells were treated with higher concentration (0.5 mg/ml) of anti-Fas antibody. In Hep39 cells, however, 0.1 mg/ml of the antibody was sufficient to induce apoptotic changes (data not shown).
Expression of surface Fas antigen
We then examined the association between Fas antigen expression on the cell surface and intracellular presence of HCV core protein by flow cytometric analysis using anti-Fas mAb. The number of cells expressing Fas antigen was not significantly different in core-expressing cells (92%) compared to those of the controls, HepG2 and Hepswx (88 and 81%, respectively) ( Table 1 ). In addition, the expression levels of surface Fas did not show significant changes between Hep39 cells (intensity of surface Fas: 30) and controls (intensity of surface Fas: anti-Fas-induced apoptosis in Hep39 cells.
inhibitor (30%). Fas-mediated apoptosis of HepG2 cells apoptotic cell death may account for the liver cell damage observed in acute and chronic hepatitis. Apoptosis of hepaharboring HCV core protein was prevented by Ac-DEVDcho, but not by Ac-YVAD-cho.
tocytes in viral hepatitis may also give clues to understand the discordance between serum transaminase values and the degree of histological injury (Que et al., 1996) . DISCUSSION Apoptosis under physiological cell conditions is a twophase process. In the first phase, even if they look norIn spite of the lack of an in vitro cell system to support the efficient replication of HCV, the constitutive expresmal, cells are committed to undergo apoptotic death in response to various stimuli. In the second phase of sion of viral proteins in human hepatoma cell lines provides useful information for studying the effects induced apoptosis cells undergo dramatic morphological and physiological changes, culminating in cell death (Steller by expression of HCV proteins. Here we report the effect of intracellular HCV core protein in relation to Fas-mediet al., 1995) . With respect to this concept, the sensitivity to anti-Fas-triggered apoptosis in Hep39 cells described ated apoptosis.
Data have been accumulating to suggest that HCV here is considered in that the Fas transduction pathway is primed to induce apoptosis in HepG2 cells harboring core protein is a trans-acting regulatory protein. The 22-kDa core protein trans-suppressed CAT gene expression certain intracellular HCV protein. The results, together with the lack of apoptotic cell death in HepG2 cells conunder the control of various promoters (Kim et al., 1994) . It was reported to regulate the replication and the expresstitutively expressing other HCV proteins like envelope or nonstructural proteins, strongly indicate a role for HCV sion of the HBV genome (Shih et al., 1993) and to transactivate c-myc oncogene (Ray et al., 1995) . HCV core core protein in making cells prone to undergo apoptosis. Therefore, core protein may have an indirect role in mediprotein enhanced the H-ras oncogene activity in immortalizing rat embryo fibroblast (Ray et al., 1996) . These ating HCV-induced liver cell damage and in the proposed immune-mediated cytopathogenicity. observations suggest that HCV core protein functions not only as a structural nucleocapsid protein but also as
The lack of a significant difference in the expression level of surface Fas antigen between Hep39 and control a regulatory protein of gene expression.
Apoptosis, a cellular genetic program leading to cell Hepswx and HepG2 cells suggests that expression levels of Fas antigen on the cell surface can be dissociated shrinkage, cytoplasmic blebbing, and cleavage of chromosomal DNA, is a cellular response to various stimuli. from its mediation of an apoptotic effect. Furthermore, it indicates that the apoptotic priming effect of HCV core Both physiological and pathological stimuli including viral infections induce apoptosis (see Vaux and Strasser, protein is not associated with the upregulation of surface Fas antigen. The independence of apoptosis priming 1996, for review). The mechanisms by which a virus activates the apoptotic pathway in infected cells are not from Fas antigen expression level in Hep39 cells suggests that the apoptosis effector pathway located downknown. Although intracellular synthesis of viral proteins is generally required, expression of single viral protein stream of the surface Fas is affected by HCV core protein.
Such an effect of HCV core protein makes the cells highly may be sufficient. Apoptosis, for instance, is associated with chicken anemia virus VP3 protein (Noteborn et al., susceptible to anti-Fas antibody. Protease activity has been described to have a promi-1994) and with human T-cell leukemia virus Tax protein (Yamada et al., 1994) . Fas agonists induced typical nent role in apoptotic cell death (see Seamus and Douglas, 1995, for review) . In mammalian cells, the ICE family apoptosis in primary T lymphocytes from HIV-infected patients and in CD4/ cell lines expressing viral gp160 of proteases includes at least seven recently identified members, whose prototypes are ICE, CPP32, and Ich-1 (Estaquier et al., 1996; Lu et al., 1994) .
In addition to direct viral cytotoxicity, apoptotic cell death (Duan et al., 1996) . Inhibition by Ac-DEVD-cho peptide indicates that Fas-mediated apoptosis in Hep39 cells during viral infection can occur as a result of an immune response mediated by cytotoxic T lymphocytes (CTL). Since involves the preferential activation of CPP32. Moreover, this result suggests that the apoptotic machinery of liver cells were shown to be sensitive to induction of apoptosis by agonists of Fas antigen both in primary human Hep39 cells shares the effector pathway of the Fas-induced death signal reported for other cell systems, such hepatocytes in vitro (Galle et al., 1995) and in murine model in vivo (Ogasawara et al., 1993) , the release of soluble Fas as some T lymphoid cells. In addition, as CPP32 activation has been shown to be a downstream event in the ligand into systemic circulation from activated CTLs may contribute to the hepatocyte injury (Que et al., 1996) . In fact, apoptotic pathway (Greidinger et al., 1996) , commitment to apoptosis mediated by HCV core protein may involve the expression of Fas antigen was shown in the liver tissue in patients with hepatitis C, with a higher prevalence in an upstream event(s) which is not known yet.
In conclusion, by stimulation with anti-Fas antibody, regions of active inflammation (Hiramatsu et al., 1994) . Moreover, expression of Fas ligand was reported in liverwe could demonstrate apoptotic cell death in a human hepatoma cell line constitutively expressing HCV core infiltrating mononuclear cells in patients with hepatitis C (Mita et al., 1994) . From the observations described above, protein. This may help to explore the new aspects of
